Erratum: Phase I trial of rituximab, cladribine, and temsirolimus (rct) for initial therapy of mantle cell lymphoma (Annals of Oncology (2014) 25 (2020-2024) DOI: 10.1093/annonc/mdu273)

D. J. Inwards, P. A. Fishkin, B. R. Laplant, M. T. Drake, P. J. Kurtin, D. A. Nikcevich, D. B. Wender, B. S. Lair, T. E. Witzig

Research output: Contribution to journal › Comment/debate › peer-review

Fingerprint

Dive into the research topics of 'Erratum: Phase I trial of rituximab, cladribine, and temsirolimus (rct) for initial therapy of mantle cell lymphoma (Annals of Oncology (2014) 25 (2020-2024) DOI: 10.1093/annonc/mdu273)'. Together they form a unique fingerprint.

Medicine & Life Sciences